Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Left ventricular reverse remodelling after aortic valve replacement with angiotensin II receptor blockade
2005-001930-34Phase 3Completed
- Sponsor
- University Hospital Odense
- Start
- Nov 2005
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of candesartan in aortic stenosis (AS) and left ventricular remodelling, sponsored by University Hospital Odense. Started Nov 2005; status: completed.
02
Drugs
candesartan
03
Conditions
aortic stenosis (AS)left ventricular remodelling
Beyond the preview
Go deeper on 2005-001930-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001930-34.